STRR:NASDAQStar Equity Holdings, Inc. Analysis
Data as of 2026-06-12 - not real-time
$11.04
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Star Equity Holdings posted a spectacular 57% year‑over‑year revenue surge to $50.1 M in Q1 FY2026, with gross profit climbing 25% to $20.6 M, driven by energy‑services momentum and merger synergies. Despite the top‑line strength the company still reported a $3.8 M loss and negative cash flows, highlighting the need for the announced $8‑10 M real‑estate monetization to shore up liquidity. On the valuation side, the stock trades at a forward P/E of 8.98 versus an industry average of 30.6 and a price‑to‑book of 0.67, suggesting it is significantly undervalued with a consensus upside of roughly 66% and a strong‑buy analyst consensus. Technically, the price sits just below the 20‑day SMA (11.14) but above the 50‑day and 200‑day averages, the RSI is neutral at 52, and the MACD has turned bearish, while volume is rising and volatility remains high at 45%.
The low beta of 0.28 points to limited market‑wide systematic risk, yet the high 30‑day volatility and a recent max drawdown of over 21% signal considerable price swings. The balance sheet shows $12.3 M cash against $26.7 M debt (debt‑to‑equity ~44%), and operating cash flow remains negative, underscoring liquidity concerns. With no regular dividend and only a preferred dividend issuance, income‑focused investors should be cautious. Overall, the company’s growth narrative, deep discount to peers, and upcoming monetization initiatives create a compelling upside case, but the near‑term technical weakness and cash‑flow deficits temper short‑term optimism.
The low beta of 0.28 points to limited market‑wide systematic risk, yet the high 30‑day volatility and a recent max drawdown of over 21% signal considerable price swings. The balance sheet shows $12.3 M cash against $26.7 M debt (debt‑to‑equity ~44%), and operating cash flow remains negative, underscoring liquidity concerns. With no regular dividend and only a preferred dividend issuance, income‑focused investors should be cautious. Overall, the company’s growth narrative, deep discount to peers, and upcoming monetization initiatives create a compelling upside case, but the near‑term technical weakness and cash‑flow deficits temper short‑term optimism.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and price near support
- High 30‑day volatility
- Increasing volume indicating possible short‑term swing
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained revenue growth and improving gross profit
- Undervalued relative to industry multiples
- Planned real‑estate monetization to improve cash position
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Diversified business segments across geographies
- Low beta suggests resilience to market cycles
- Significant upside potential versus current price
Key Metrics & Analysis
Financial Health
Revenue Growth57.10%
Profit Margin-4.18%
P/E Ratio9.0
ROE-15.83%
ROA-2.13%
Debt/Equity43.85
P/B Ratio0.7
Op. Cash Flow$-7849000
Free Cash Flow$-13630750
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI52.4
Support$9.70
Resistance$11.91
MA 20$11.14
MA 50$10.21
MA 200$10.36
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Target Price$18.33
Upside/Downside66.06%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.28
Volatility45.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.